Funding Opportunities

Person planting a seed in the ground

Intramural Funding

The UCLA Jonsson Comprehensive Cancer Center facilitates multiple intramural funding programs, including for seed grant, tumor specific projects, fellowships, and more. To administer these funding programs, we've established an online funding portal where you can learn about the different opportunities available to you, as well as download and submit applications

Called UCLA Bruin Learn, click the button below to access the portal. A one-time registration is required and you will need a UCLA Logon ID to use Bruin Learn. (If you do not already have a UCLA Logon ID, please visit this page to create one.)

Access Bruin Learn

Extramural Limited Submission Funding Opportunities

Below is a list of limited extramural funding opportunities that are provided as a courtesy to UCLA Health Jonsson Comprehensive Cancer Center members. For an opportunity to be included on this list, it must be a Limited Submission Opportunity (LSO) and applications are supported administratively by the Cancer Center’s Grants Facilitation Team. Submission instructions are noted below. If you have any questions about a specific LSO listed below, please contact Sarah Anwar via email.

Listings are generally updated on a bimonthly basis. Entries are ordered by posting date, with most recent postings first. Opportunities are removed from this list once their final application due date has passed.

Posted December 1, 2023

NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 Independent Clinical Trial Required)

The purpose of the NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00) program is to increase and maintain a strong cohort of new and talented, NCI-supported, independent investigators. This program is designed for postdoctoral fellows with research and/or clinical doctoral degrees who do not require an extended period of mentored research training beyond their doctoral degrees. The objective of this award is to facilitate a timely transition of these fellows from their mentored, postdoctoral research positions to independent tenure-track (or equivalent) faculty positions. The program will provide independent NCI research support during this transition to help awardees launch competitive, independent research careers. Researchers in the scientific areas of cancer control, cancer prevention and cancer data sciences are especially encouraged to work with their institutions to apply.

For more information, please visit the NCI website.

Deadline
One-page research summary and biosketch due to the Cancer Center by December 15, 2023. If your project is selected by the Cancer Center, please be prepared to submit a full application by February 14, 2024.

How to apply
If you are interested in being considered for this CCSG supplement please respond with a one-page research summary along with your Biosketch to Sarah Anwar at [email protected] and Genevieve Ortega-Alves at [email protected].

NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 Independent Clinical Trial Not Allowed)

The purpose of the NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00) program is to increase and maintain a strong cohort of new and talented, NCI-supported, independent investigators. This program is designed for postdoctoral fellows with research and/or clinical doctoral degrees who do not require an extended period of mentored research training beyond their doctoral degrees. The objective of this award is to facilitate a timely transition of these fellows from their mentored, postdoctoral research positions to independent tenure-track (or equivalent) faculty positions. The program will provide independent NCI research support during this transition to help awardees to launch competitive, independent research careers. Researchers in the scientific areas of cancer control, cancer prevention and cancer data sciences are especially encouraged to work with their institutions to apply.

For more information, please visit the NCI website.

Deadline
One-page research summary and biosketch due to the Cancer Center by December 15, 2023. If your project is selected by the Cancer Center, please be prepared to submit a full application by February 14, 2024.

How to apply
If you are interested in being considered for this CCSG supplement please respond with a one-page research summary along with your Biosketch to Sarah Anwar at [email protected] and Genevieve Ortega-Alves at [email protected].

NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 Independent Basic Experimental Studies with Humans Required)

The purpose of the NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00) program is to increase and maintain a strong cohort of new and talented, NCI-supported, independent investigators. This program is designed for postdoctoral fellows with research and/or clinical doctoral degrees who do not require an extended period of mentored research training beyond their doctoral degrees. The objective of this award is to facilitate a timely transition of these fellows from their mentored, postdoctoral research positions to independent tenure-track (or equivalent) faculty positions. The program will provide independent NCI research support during this transition to help awardees launch competitive, independent research careers. Researchers in the scientific areas of cancer control, cancer prevention and cancer data sciences are especially encouraged to work with their institutions to apply.

For more information, please visit the NCI website.

Deadline
One-page research summary and biosketch due to the Cancer Center by December 15, 2023. If your project is selected by the Cancer Center, please be prepared to submit a full application by February 14, 2024.

How to apply
If you are interested in being considered for this CCSG supplement please respond with a one-page research summary along with your Biosketch to Sarah Anwar at [email protected] and Genevieve Ortega-Alves at [email protected].

Posted November 16, 2023

Mary Kay Ash Foundation Innovative/Translational Cancer Research Grant

The Mary Kay Ash Foundation, a funding source for cancer research, is currently accepting applications for innovative grants for translational research of cancers affecting women, including but not limited to breast, cervical, endometrial, ovarian, uterine or cancers predominantly affecting women. Grants will be awarded in the amount of $100,000 over a two-year period.

  • Grants are by invitation only
  • Only one grant application will be accepted from each accredited cancer research institute or medical school. It is up to each institute to conduct an internal review process to determine their applicant. No exceptions.
  • Principal Investigator must be appointed a full-time assistant professor or higher at the time of application submission and commit a minimum 5 percent effort
  • All text and general page formatting guidelines should adhere to NIH-format, which can be referenced on the NIH website here
  • If you are applying on behalf of a PI, you must use the PI’s first and last name to create the GrantsConnect User Profile Login. The User Profile generates the name the Research Review Committee sees when reviewing submissions
  • Please review the FAQs section and Applicant User Guide for additional questions you may encounter

Deadline
One-page research summary and biosketch due to the Cancer Center by December 1, 2023. If your project is selected by the Cancer Center, please be prepared to submit a full application by February 1, 2024.

How to apply
If you are interested in being considered for this CCSG supplement please respond with a one-page research summary along with your Biosketch to Sarah Anwar at [email protected] and Genevieve Ortega-Alves at [email protected].

Posted October 2, 2023

Damon Runyon Cancer Research Foundation Clinical Investigator Award

The Damon Runyon Clinical Investigator Award supports independent young physician-scientists conducting disease-oriented research that demonstrates a high level of innovation and creativity. The goal is to support the best young physician-scientists doing work aimed at improving the practice of cancer medicine.

Deadline
One-page research summary and biosketch due to the Cancer Center by November 17, 2023. If your project is selected by the Cancer Center, please be prepared to submit a full application by February 1, 2024 at 1:00 p.m. PST.

How to apply
If you are interested in being considered for this CCSG supplement please respond with a one-page research summary along with your Biosketch to Sarah Anwar at [email protected] and Genevieve Ortega-Alves at [email protected].

Posted September 27, 2023

National Cancer Institutes (NCI) Early Career Cancer Clinical Investigator Award P30 Administrative Supplement for Fiscal Year 2024

Formerly the Cancer Clinical Investigator Team Leadership Award, the Early Career Cancer Clinical Investigator Award (ECIA) recognizes and supports outstanding early career clinical investigators who demonstrate a commitment to becoming an academic clinical researcher and supporting their cancer center’s NCI-funded clinical trials enterprise. The ECIA is designed to promote the retention of early career investigators who wish to initiate a career path that focuses on interventional cancer clinical trials and academic clinical research. The award provides salary support to individuals who do not have independent research grant funding as a Principal Investigator.

The total supplement budget cannot exceed $60,000 (total costs) per year for a total of two years, meaning that with the 57.5 percent F&A rate that goes into effect in July 2024, the annual direct cost is $38,095. The only allowable costs are salary and fringe benefits, and up to $2,500/year for travel and registration fees to attend courses, seminars, meetings, conferences, etc… that directly relates to the intent of the award.

Deadline
One-page research summary and biosketch due to the Cancer Center by Friday, October 13, 2023. If your project is selected by the Cancer Center, please be prepared to submit a full application by December 18, 2023 at 5pm PST.

How to apply
If you are interested in being considered for this CCSG supplement please respond with a one-page research summary along with your Biosketch to Sarah Anwar at [email protected] and Genevieve Ortega-Alves at [email protected].

Posted September 1, 2023

National Cancer Institutes (NCI) Administrative Supplements to Participate in Early-Stage Surgeon Scientist Program

This Notice of Special Interest from the NCI announces an opportunity for administrative supplement funding to support and train early-stage surgeon scientists conducting cancer-related research and with the goal to accelerate them into an independent surgeon scientist career. The NCI will support exceptional surgeon scientists from across the United States who have not received prior substantial NIH funding to be trained together by participating in the NCI Early-stage Surgeon Scientist Program (ESSP). This 5-year pilot program will support early-career surgeon scientist program participants, each of whom will receive three years of funding in three cohorts, staggered a year apart.

Please see these link for more information about this opportunity: https://grants.nih.gov/grants/guide/notice-files/NOT-CA-21-100.html and https://www.cancer.gov/grants-training/training/funding/nci-essp. 

Deadline
One-page research summary and biosketch due to the Cancer Center by Monday, September 22, 2023. If your project is selected by the Cancer Center, please be prepared to submit a full application by December 8, 2023 at 5pm PST.

How to apply
If you are interested in being considered for this CCSG supplement please respond with a one-page research summary along with your Biosketch to Sarah Anwar at [email protected] and Genevieve Ortega-Alves at [email protected].